Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks
Several years ago, a little-known drug named Ozempic – previously used only to treat diabetes – emerged as a promising new drug for weight management. The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists,
The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...
The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...
If you're using GLP-1 medications like Ozempic, Wegovy, or Mounjaro, you know how important it is to prioritize protein ...
Allurion stock soars on weight-loss therapy update. Stardust Power breaks ground on Oklahoma lithium refinery. OpenAI ...
If your constipation lasts for more than three days, speak with your doctor about options to help. You might need to add a ...
If you're looking for a meal that’s quick, flavorful, and packed with protein, these Spicy Sriracha Lime Shrimp Bowls ar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback